Product NDC: | 52584-165 |
Proprietary Name: | Dexamethasone Sodium Phosphate |
Non Proprietary Name: | Dexamethasone Sodium Phosphate |
Active Ingredient(s): | 4 mg/5mL & nbsp; Dexamethasone Sodium Phosphate |
Administration Route(s): | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52584-165 |
Labeler Name: | General Injectables & Vaccines, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA084916 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110718 |
Package NDC: | 52584-165-05 |
Package Description: | 1 VIAL, MULTI-DOSE in 1 BAG (52584-165-05) > 5 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 52584-165-05 |
Proprietary Name | Dexamethasone Sodium Phosphate |
Package Description | 1 VIAL, MULTI-DOSE in 1 BAG (52584-165-05) > 5 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 52584-165 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Dexamethasone Sodium Phosphate |
Dosage Form Name | INJECTION |
Route Name | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20110718 |
Marketing Category Name | ANDA |
Labeler Name | General Injectables & Vaccines, Inc. |
Substance Name | DEXAMETHASONE SODIUM PHOSPHATE |
Strength Number | 4 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |